SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: harkenman who wrote (330)12/9/1999 7:53:00 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3557
 
Nice milestone. <eom>

biz.yahoo.com
<<Commercial production of the intermediate under Regeneron's long-term manufacturing agreement with Merck will extend over the next six years. Payments from Merck will depend on the volume of intermediate supplied each year. At the minimum quantities in the agreement, total payments over the six years are expected to be in excess of $50 million. >>